NovoCure Ltd — Director's Dealing 2023

May 11, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NovoCure Ltd (NVCR)
CIK: 0001645113
Period of Report: 2023-05-09

Reporting Person: Stafford Kristin (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-05-09	Stock Option (Right to Buy)	$72.02	A	15873.00	Acquired	2033-05-08	Ordinary Shares (15873.00)	Direct

Footnotes

F1: These stock options will vest in equal parts on the first, second and third anniversary of the grant date.